Advertisement

Topics

Lessening the Burden of Non-Communicable Diseases

10:40 EDT 17 Aug 2017 | 3blmedia - Health

SOURCE: Pfizer

DESCRIPTION:

Fundamental to Pfizer’s approach in supporting global health is helping to ensure that individuals have the opportunity to lead healthy lives.

As a part of its approach, the Pfizer Foundation is supporting projects in eight countries to help lessen the burden of non-communicable diseases (NCDs). These programs aim to increase community awareness of risk factors and preventative measures for NCDs, improve early detection and diagnosis, and increase capacity of community health centers. For example, Pfizer has partnered with FHI 360, an international nongovernmental organization (NGO), to establish a community-based, integrated NCD prevention and control program in Vietnam.

The Pfizer Foundation is also working with organizations to improve access to equitable oncology services, with a focus on women’s cancers, and is exploring opportunities to make oncology outreach, early screening and diagnosis more accessible to underserved women. Projects include a community-based breast cancer program in Peru to improve early detection and link to treatment and services at the national level, along with an initiative to integrate breast cancer patient support, detection and diagnosis into existing primary care services in Northeast Brazil.

Learn more about the Pfizer Foundation’s global health strategy: http://on.pfizer.com/2vm6BN0

The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.

Tweet me: Find out how #PfizerFdn is helping lessen the burden of #NCDs for underserved individuals around the world: http://bit.ly/2we4cF2

KEYWORDS: Health & Healthcare, Philanthropy & Cause Initiatives, Pfizer, Pfizer Foundation, entrepreneurs, Innovation, non-communicable diseases, NCDs, access, medicines, Corporate Social Responsibility, sustainability

Original Article: Lessening the Burden of Non-Communicable Diseases

NEXT ARTICLE

More From BioPortfolio on "Lessening the Burden of Non-Communicable Diseases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...